Website stats for Galectintherapeutics - galectintherapeutics.com
What We DoGalectin's lead drug, belapectin (GR‑MD‑), is a carbohydrate-based drug that inhibits the galectin‑ protein, involved in many inflammatory, fibrotic, and malignant diseases. Learn More
galectintherapeutics.com was registered 1 decade 4 years ago. It has a alexa rank of #2,075,178 in the world. It is a domain having .com extension. It is estimated worth of $ 720.00 and have a daily income of around $ 3.00. As no active threats were reported recently, galectintherapeutics.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 422 |
| Daily Pageviews: | 844 |
Estimated Valuation
| Income Per Day: | $ 3.00 |
| Estimated Worth: | $ 720.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 2,075,178 |
| PageSpeed Score: | 89 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
66.96.161.165
Hosted Country:
US
Location Latitude:
42.5085Location Longitude:
-71.2011Traffic Classification
| Total Traffic: | No Data |
| Direct Traffic: | No Data |
| Referral Traffic: | No Data |
| Search Traffic: | No Data |
| Social Traffic: | No Data |
| Mail Traffic: | No Data |
| Display Traffic: | No Data |
Search Engine Results For galectintherapeutics.com
Galectin Therapeutics Inc SEC Registration - SEC Report
Galectin Therapeutics Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page ...
Galectin Therapeutics Company Profile: Stock Performance ...
Information on stock, financials, earnings, subsidiaries, investors, and executives for Galectin Therapeutics. Use the PitchBook Platform to explore the full profile.
Galectin Therapeutics - Overview, News & Competitors | ZoomInfo.com
View Galectin Therapeutics (www.galectintherapeutics.com) location in Georgia, United States , revenue, industry and description. Find related and similar ...
GALT.DF - Galectin Therapeutics Inc Profile | Reuters
About Galectin Therapeutics Inc ... Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in drug research and development to create ...
Galectins and Disease Implications for Targeted ... - ACS Publications
Galectin Therapeutics, Inc., 4960 Peachtree Industrial Blvd., Suite 240,. Norcross, Georgia 30071. *E-mail: [email protected] (A.A.K);.
Galectin Therapeutics Company Profile - Office Locations ... -...
Galectin Therapeutics has 7 employees at their 1 location. See insights on Galectin Therapeutics including office locations, competitors, revenue, financials, ...
Galectin Therapeutics Inc (GALT) Quote - XNAS | Morningstar
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for ...
Galectin Therapeutics Inc - Company Profile and News - Bloomberg ...
Galectin Therapeutics Inc. is a drug development company. The Company creates new therapies for fibrotic disease and cancer using its carbohydrate ...
GALT - Galectin Therapeutics Inc | Profile | OTC Markets
Galectin Therapeutics leverages its extensive scientific knowledge of galectins to advance their discovery program including research and discovery of new ...
Galectin Therapeutics Inc. (Nasdaq: GALT) :: LD Micro
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for ...
Fighting NASH Cirrhosis and Cancer
Galectin Therapeutics looks to help patients with NASH cirrhosis and cancer. Galectin's lead drug (GR-MD-02, or belapectin) is a galectin-3 inhibitor.
Galectin Therapeutics: The Galectin Signature - Signed, Sealed ...
Apr 16, 2021 ... Galectin Therapeutics (GALT) was founded years ago building on the research of professors from Harvard and Weizmann, and has undergone ...
Galectin Therapeutics | The Org
Galectin Therapeutics Inc (NASDAQ: GALT) is developing medical therapies for liver fibrosis and cancer by targeting galectin proteins.
Galectin's Competitors, Revenue, Number of Employees, Funding ...
Website: http://galectintherapeutics.com/ ... Galectin Therapeutics Inc., the leading developer of therapeutics that target galectin proteins, repo... See more » .
288: The Big Year | Jack Callicutt, CFO, Galectin Therapeutics -...
288: The Big Year | Jack Callicutt, CFO, Galectin Therapeutics. To span the realm of opportunities in biotech is to gaze down an infinite loop of possibilities with ...
GALT: Galectin Therapeutics Inc. - Summary | Jitta
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other ...
Atlanta : Galectin Therapeutics Raises $44.5 Million in ... -...
May 28, 2019 ... NORCROSS, Ga., May 28, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics ...
Galectin Therapeutics Inc company profile - Futubull
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other ...
Galectin Therapeutics And CTI Announce Positive New Psoriasis ...
Galectin Therapeutics is developing promising carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the Company's ...
Galectin Therapeutics Stock Analysis | GALT Stock Rating - TipRanks
Galectin Therapeutics stock analysis based on the TipRanks smart score of 8 unique data sets and technical analysis. Find the latest GALT stock analysis.
Galectin Therapeutics Inc. Warrants (GALTW) Stock Message Board ...
Company Name: Galectin Therapeutics Inc. Warrants, Stock Symbol: GALTW, Industry: Biotechs, Total Posts: 16, Last Post: 8/15/2014 8:34:32 PM.
Jobs with Galectin Therapeutics - BioSpace
Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and provided a ...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 1 | H2 Headings: | 6 |
| H3 Headings: | 5 | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 5 |
| Google Adsense: | Not Applicable | Google Analytics: | UA-23609777-1 |
Two Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Learn More | 10 | 2.198 % | No |
| NASH cirrhosis | 7 | 1.538 % | No |
| Galectin Therapeutics | 5 | 1.099 % | No |
| the NAVIGATE | 3 | 0.659 % | No |
| We Do | 3 | 0.659 % | No |
| What We | 3 | 0.659 % | No |
| Email Alert | 3 | 0.659 % | No |
| Alert Subscription | 3 | 0.659 % | No |
| News Contact | 2 | 0.44 % | No |
| Publications News | 2 | 0.44 % | No |
| Contact Us | 2 | 0.44 % | No |
| hope to | 2 | 0.44 % | No |
| Resources Publications | 2 | 0.44 % | No |
| cirrhosis is | 2 | 0.44 % | No |
| steatohepatitis NASH | 2 | 0.44 % | No |
| About the | 2 | 0.44 % | No |
| Belapectin About | 2 | 0.44 % | No |
| About Belapectin | 2 | 0.44 % | No |
| More About | 2 | 0.44 % | No |
| About Galectin3 | 2 | 0.44 % | No |
Four Phrase Analysis
| Words | Occurrences | Density | Possible Spam |
|---|---|---|---|
| Learn More About Belapectin | 2 | 0.44 % | No |
| Subscription Learn More About | 2 | 0.44 % | No |
| Alert Subscription Learn More | 2 | 0.44 % | No |
| More About Belapectin About | 2 | 0.44 % | No |
| About Belapectin About Galectin3 | 2 | 0.44 % | No |
| About Galectin3 About the | 2 | 0.44 % | No |
| Belapectin About Galectin3 About | 2 | 0.44 % | No |
| Email Alert Subscription Learn | 2 | 0.44 % | No |
| FAQs Email Alert Subscription | 2 | 0.44 % | No |
| Governance Financial Information Stock | 2 | 0.44 % | No |
| Corporate Governance Financial Information | 2 | 0.44 % | No |
| Financial Information Stock Information | 2 | 0.44 % | No |
| Information Stock Information FAQs | 2 | 0.44 % | No |
| Information FAQs Email Alert | 2 | 0.44 % | No |
| Stock Information FAQs Email | 2 | 0.44 % | No |
| Galectin3 About the NAVIGATE | 2 | 0.44 % | No |
| About the NAVIGATE Study | 2 | 0.44 % | No |
| malignant diseases Learn More | 2 | 0.44 % | No |
| and malignant diseases Learn | 2 | 0.44 % | No |
| fibrotic and malignant diseases | 2 | 0.44 % | No |
Websites Hosted on Same IP (i.e. 66.96.161.165)
South Carolina Search Engine Optimization & Web Design Company -...
PalmettoSoft is a SC based SEO & Digital Marketing company providing expert level SEO & Digital Marketing services for improved search rankings and increased traffic.
421,482 
$ 10,080.00
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Date: Sun, 20 Jun 2021 19:22:39 GMT
Content-Type: text/html; charset=UTF-8
Content-Length: 7585
Connection: keep-alive
Server: Apache/2
X-Powered-By: PHP/7.3.2
Link:
Vary: Accept-Encoding,User-Agent
Content-Encoding: gzip
Age: 3
Domain Information
| Domain Registrar: |
GoDaddy.com, LLC
|
|---|---|
| Registration Date: | 2010-02-13 1 decade 4 years 9 months ago |
| Last Modified: | 2020-01-13 4 years 10 months 6 days ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns47.domaincontrol.com | |
97.74.103.24 | United States |
| ns48.domaincontrol.com | |
173.201.71.24 | United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| galectintherapeutics.com | A | 1792 |
IP: 66.96.161.165 |
| galectintherapeutics.com | NS | 3600 |
Target: ns47.domaincontrol.com |
| galectintherapeutics.com | NS | 3600 |
Target: ns48.domaincontrol.com |
| galectintherapeutics.com | SOA | 3600 |
MNAME: ns47.domaincontrol.com RNAME: dns.jomax.net Serial: 2021041204 Refresh: 28800 Retry: 7200 Expire: 604800 |
| galectintherapeutics.com | MX | 3600 |
Target: galectintherapeutics-com.mail.protection.outlook.com |
| galectintherapeutics.com | TXT | 3600 |
TXT: v=spf1 include:spf.smarsh.com include:spf.protection.outlook.com -all |
| galectintherapeutics.com | TXT | 3600 |
TXT: v=verifydomain MS=6038271 |
Full WHOIS Lookup
Registry Domain ID:
1585206836_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.godaddy.com
Registrar URL:
http://www.godaddy.com
Updated Date:
2020-01-13T14:20:09Z
Creation Date:
2010-02-12T16:12:27Z
Registry Expiry Date:
2022-02-12T16:12:27Z
Registrar: GoDaddy.com, LLC
Registrar
IANA ID: 146
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
480-624-2505
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientRenewProhibited
https://icann.org/epp#clientRenewProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
NS47.DOMAINCONTROL.COM
Name Server:
NS48.DOMAINCONTROL.COM
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2021-06-20T19:22:25Z
Similarly Ranked Websites
FRONTOWIEC.COM
Jesteśmy fascynatami militarnej historii ostatnich czasów. Kolekcjonujemy wszelkiego typu militaria i materiały historyczne.
2,075,213 $ 720.00
Génération Nintendo : Actu, Critiques, Passion
Joignez-vous à une communauté active, chaleureuse et passionnée de fans de Nintendo, et découvrez nos news, tests, dossiers, astuces, fiches et bien plus encore !
2,075,221 $ 720.00
Fraser – Leader in Autism Services Other Special Needs |...
Fraser serves children and adults with special needs through comprehensive education, healthcare and housing services. Fraser is Minnesota's largest and most experienced...
2,075,241 $ 720.00
Пчёлка - медовые рецепты, все о мёде и пчёлах
На сайте вы можете найти информацию о мёде, пчёлах и продуктах пчеловодства.
2,075,257 $ 720.00